您好,欢迎来到试剂信息网! [登录] [免费注册]
试剂信息网
位置:首页 > 产品库 > Everafenib
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Everafenib
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
包装与价格:
包装价格(元)
5 mg电议
50 mg电议
100 mg电议

产品介绍
Everafenib 是一种有效且具有血脑屏障透过性的BRAF抑制剂,也抑制MAPK通路。Everafenib 对一系列V600EBRAF 黑色素瘤细胞系具有抑制活性,IC50范围为 2-10 nM,优于Dabrafenib 和Vemurafenib。Everafenib 能有效提高颅内转移性黑色素瘤小鼠模型的存活天数。

产品描述

Everafenib is a potent and blood-brain barrier (BBB) penetrant BRAF inhibitor, also inhibits MAPK signaling. Everafenib has inhibitory activity against a panel of V600E BRAF melanoma cell lines with IC 50 values of 2-10 nM, which is better than Dabrafenib and Vemurafenib. Everafenib has efficacy in an intracranial mouse model of metastatic melanoma [1].

体外活性

Everafenib (1-10 μM; 1 or 24 h) inhibits MAPK signaling in A375 cells [1]. Western Blot Analysis [1] Cell Line: A375 ( V600E BRAF) Concentration: 0.01, 0.1, 1 and 10 μM Incubation Time: 1 or 24 h Result: Inhibited phospho-ERK1/2 in a dose-dependent manner, also inhibited phospho-MEK1/2.

体内活性

Everafenib (50 mg/kg; IP; once daily, for 5 days) increases median survival of melanoma mice from 39 to 50.5 days [1]. Animal Model: Female athymic nude mice (intracranially injected with 5×10 4 A375 melanoma cells) [1] Dosage: 50 mg/kg Administration: IP; once daily, for 5 days Result: Increased median survival from 39 to 50.5 days, and outperformed Dabrafenib.

分子式

C20H23ClFN5O2S2

分子量

484.01

储存和溶解度

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years